News

Generic melphalan available in US


 

Photo from Business Wire

Fresenius Kabi’s Melphalan Hydrochloride for Injection

Fresenius Kabi’s Melphalan Hydrochloride for Injection, a generic version of Alkeran®, is now available in the US.

Melphalan Hydrochloride for Injection is available as a 2-vial kit containing 1 single-dose vial of melphalan hydrochloride equivalent to 50 mg of melphalan and 1 vial of sterile diluent.

Melphalan Hydrochloride for Injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.

For more details on Melphalan Hydrochloride for Injection, see the full prescribing information.

Recommended Reading

European Commission expands denosumab indication
MDedge Hematology and Oncology
Age and race affect access to myeloma treatment
MDedge Hematology and Oncology
Generic antiemetic now available in US
MDedge Hematology and Oncology
Group identifies novel genes involved in MM development
MDedge Hematology and Oncology
Selinexor receives fast track designation for MM
MDedge Hematology and Oncology
Screening may reduce prevalence of MM
MDedge Hematology and Oncology
EC expands indication for denosumab to MM
MDedge Hematology and Oncology
CHMP supports expanded approval for fosaprepitant
MDedge Hematology and Oncology
CHMP rejects plitidepsin again
MDedge Hematology and Oncology
GPS consolidation may prolong PFS after ASCT
MDedge Hematology and Oncology